Team
Jane Theaker is an experienced CEO, NED, and diagnostics expert who developed a technology sold to Qiagen for $130M. She has held roles at NHS, AstraZeneca, Qiagen, and others, focusing on diagnostics. A former CEO of Kinomica and PBD Biotech, she's an NED at Bionow and advises small businesses on strategy. She’s passionate about advancing lifesciences innovations.
Mondana Cook is an experienced executive with ~30 years of expertise in strategy, program management, and translating new technologies into products. Formerly COO at Kinomica and PBD Biotech, she also led major R&D projects at QIAGEN ($100M+). She excels in complex ventures, strategy execution, and scaling operations for innovative diagnostics and patient impact.
Joely Irlam, CTO, has 25+ years of cancer research experience, 16 years in developing hypoxia biomarkers, and co-founded ManTRa Diagnostics as CEO to deliver precision cancer genomic tests. She’s on the BREACH steering group to promote academic-industry collaboration for advancing translational science.
Maddy Kennedy is an experienced CFO with 25+ years in life sciences and tech sectors, focusing on SMEs. She has led M&A, IPOs, fundraising, and exits. Recent roles include CFO at Kesmalea Therapeutics and Arquer Diagnostics. NED roles include Nuformix and Tetris Pharma. FCCA-qualified, she holds a Postgraduate Diploma in Financial Strategy from Oxford.
SpinXperts
Our Mission
At the heart of SpinXperts is our exceptional team of professionals who possess a deep understanding of the needs of University Technology Transfer Offices, new spin out companies, life sciences commercialisation and a passion for delivering outstanding client service.